Author: Business Wire

Riassunto: Oraya Therapeutics riceve il parere di associazioni di categoria tedesche sull’uso della radioterapia per il trattamento della degenerazione maculare legata all’età (DMLE) essudativa

NEWARK, California–(BUSINESS WIRE)–Oraya Therapeutics ha annunciato in data odierna che la Società di oftalmologia tedesca, la Società per la retina e l’Associazione professionale degli oftalmologi tedeschi hanno rilasciato un parere congiunto sull’uso coadiuvante della radioterapia insieme al sistema di radioterapia stereotassica IRay® per il trattamento della degenerazione maculare neovascolare legata all’età. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la

CEDARS/ASPENS announces it has received Annual Sponsorships supporting its mission in the field of Ophthalmology.

LARGO, Fla.–(BUSINESS WIRE)–Ken Beckman, MD, President of CEDARS/ASPENS has stated, “We would like to extend our sincere thanks to Allergan, Bausch + Lomb, Shire, and Omeros for their annual support of CEDARS/ASPENS and for their enthusiasm and foresight in supporting the Society. These Annual Sponsorships as well as our Conference Sponsorships allow us to continue our work in shaping the future of anterior segment care through Innovation, Collaboration, and Education (I·C·E.) We look forward

Ocular Therapeutix™ Begins Enrollment in Third Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Post-Surgical Ocular Inflammation and Pain

BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced the enrollment of the first patients in a third Phase 3 clinical trial for DEXTENZATM (sustained release dexamethasone) 0.4mg Intracanalicular Depot, for the treatment of post-surgical ocular inflammation and pain. Based on the results of the Company’s two previously c

Tobii AB: Invitation to Tobii’s Conference Call Following the Q3 2015 Interim Report

STOCKHOLM–(BUSINESS WIRE)–Regulatory News: Tobii AB (STO:TOBII) plans to publish the interim report for the period January 1—September 30 on November 3 at 08.00 CET. Following this report Tobii will arrange a conference call with web cast presentation for investors, analysts and media. Tobii’s President and CEO Henrik Eskilsson and CFO Esben Olesen will present and comment on the report. After the presentation there will be time for questions. The presentation will be held in English. Time Tu

Aerpio Therapeutics to Present TIME-2 Phase 2a Study of AKB-9778 in Diabetic Macular Edema Data at 2015 American Academy of Ophthalmology Annual Meeting Retina Subspecialty Day

CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced that data from the TIME-2 Phase 2a Study of AKB-9778 in the treatment of patients with diabetic macular edema (DME) will be presented at the upcoming American Academy of Ophthalmology (AAO) Annual Meeting’s Retina Subspecialty Day. In July, the company announced data showing that a combination of AKB-9778 and Lucentis® provided significa

Robins Kaplan LLP Named Co-Lead Counsel in Disposable Contact Lens Antitrust Litigation

NEW YORK–(BUSINESS WIRE)–National law firm Robins Kaplan LLP announced today that it has been named co-lead counsel in antitrust litigation against the four dominant manufacturers and the largest nationwide distributor of contact lenses. As co-lead counsel, Robins Kaplan represents a proposed class of individual consumers that purchased contact lenses from retailers and eye care professionals that could number in the millions. Robins Kaplan filed one of the first class action complaints on be

RightEye Neuro Vision Concussion Test Unveiled at American Academy of Optometry Show

NEW ORLEANS & WASHINGTON–(BUSINESS WIRE)–RightEye LLC, a health technology company using eye tracking to revolutionize vision performance and patient care, today announced at the 2015 American Academy of Optometry show in New Orleans the launch of RightEye Neuro Vision — a new 15-second concussion test that helps health care providers more clearly understand the severity of a patient’s head trauma and better assess their recovery over time. “It’s common for concussion patients to be in denial

Walmart Outlines New Ways It Is Helping Customers Live Healthy Lives

BENTONVILLE, Ark.–(BUSINESS WIRE)–Building on its commitment to making healthcare and healthier food more affordable and accessible, Walmart today outlined additional ways the company is helping its customers live healthier lives. The retailer will focus on preventive care and supporting overall well-being across its entire assortment – in stores and online – through in-store events, online education and an expanded assortment of products and services solutions. Customers will see Walmart’s c